Guangzhou Baiyunshan Pharmaceutical Holdings Company Statistics
Total Valuation
Guangzhou Baiyunshan Pharmaceutical Holdings Company has a market cap or net worth of HKD 44.75 billion. The enterprise value is 43.95 billion.
Market Cap | 44.75B |
Enterprise Value | 43.95B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
Earnings Date | Oct 25, 2024 |
Ex-Dividend Date | Jun 13, 2024 |
Share Statistics
Guangzhou Baiyunshan Pharmaceutical Holdings Company has 1.63 billion shares outstanding. The number of shares has increased by 0.00% in one year.
Shares Outstanding | 1.63B |
Shares Change (YoY) | +0.00% |
Shares Change (QoQ) | -0.04% |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | 19.72% |
Float | 875.04M |
Valuation Ratios
The trailing PE ratio is 7.07 and the forward PE ratio is 6.71. Guangzhou Baiyunshan Pharmaceutical Holdings Company's PEG ratio is 13.77.
PE Ratio | 7.07 |
Forward PE | 6.71 |
PS Ratio | 0.35 |
PB Ratio | 0.74 |
P/FCF Ratio | n/a |
PEG Ratio | 13.77 |
Enterprise Valuation
EV / Earnings | 10.78 |
EV / Sales | 0.53 |
EV / EBITDA | 8.40 |
EV / EBIT | 9.53 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.52, with a Debt / Equity ratio of 36.43.
Current Ratio | 1.52 |
Quick Ratio | 1.14 |
Debt / Equity | 36.43 |
Debt / EBITDA | 2.85 |
Debt / FCF | n/a |
Interest Coverage | 9.89 |
Financial Efficiency
Return on equity (ROE) is 10.90% and return on invested capital (ROIC) is 5.33%.
Return on Equity (ROE) | 10.90% |
Return on Assets (ROA) | 3.54% |
Return on Capital (ROIC) | 5.33% |
Revenue Per Employee | 2.86M |
Profits Per Employee | 141,747 |
Employee Count | 28,048 |
Asset Turnover | 1.01 |
Inventory Turnover | 6.32 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.09% in the last 52 weeks. The beta is 0.55, so Guangzhou Baiyunshan Pharmaceutical Holdings Company's price volatility has been lower than the market average.
Beta (5Y) | 0.55 |
52-Week Price Change | -19.09% |
50-Day Moving Average | 19.91 |
200-Day Moving Average | 20.68 |
Relative Strength Index (RSI) | 23.45 |
Average Volume (20 Days) | 580,519 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of HKD 82.29 billion and earned 4.08 billion in profits. Earnings per share was 2.51.
Revenue | 82.29B |
Gross Profit | 14.63B |
Operating Income | 4.61B |
Pretax Income | 5.17B |
Net Income | 4.08B |
EBITDA | 5.23B |
EBIT | 4.61B |
Earnings Per Share (EPS) | 2.51 |
Balance Sheet
The company has 17.71 billion in cash and 14.92 billion in debt, giving a net cash position of 2.79 billion or 1.72 per share.
Cash & Cash Equivalents | 17.71B |
Total Debt | 14.92B |
Net Cash | 2.79B |
Net Cash Per Share | 1.72 |
Equity (Book Value) | 40.96B |
Book Value Per Share | 23.97 |
Working Capital | 19.01B |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 17.78%, with operating and profit margins of 5.60% and 4.95%.
Gross Margin | 17.78% |
Operating Margin | 5.60% |
Pretax Margin | 6.28% |
Profit Margin | 4.95% |
EBITDA Margin | 6.36% |
EBIT Margin | 5.60% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.88, which amounts to a dividend yield of 4.96%.
Dividend Per Share | 0.88 |
Dividend Yield | 4.96% |
Dividend Growth (YoY) | 1.24% |
Years of Dividend Growth | 6 |
Payout Ratio | n/a |
Buyback Yield | -0.00% |
Shareholder Yield | 4.96% |
Earnings Yield | 14.15% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |